SDZ 220-581是一种口服有效且高效的竞争性NMDA受体拮抗剂。

[1] Urwyler S,Campbell E,Fricker G,Jenner P,Lemaire M,McAllister KH,Neijt HC,Park CK,Perkins M,Rudin M,Sauter A,Smith L,Wiederhold KH,Müller W.Biphenyl-derivatives of 2-amino-7-phosphono-heptanoic acid,a novel class of potent competitive N-methyl-D-aspartate receptor antagonists--II.Pharmacological characterization in vivo.Neuropharmacology.1996 Jun;35(6):655-69.doi:10.1016/0028-3908(96)84637-5.PMID:8887975.